Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$291K Sell
5,583
-6,023
-52% -$314K ﹤0.01% 3824
2026
Q1
$537K Buy
11,606
+161
+1% +$8.47K ﹤0.01% 3283
2025
Q4
$602K Buy
+11,445
New +$580K ﹤0.01% 3059
2025
Q3
Sell
-13,758
Closed -$634K 5042
2025
Q2
$634K Buy
+13,758
New +$633K ﹤0.01% 3070
2022
Q1
Sell
-8,102
Closed -$346K 3572
2021
Q4
$346K Sell
8,102
-14,355
-64% -$700K ﹤0.01% 2370
2021
Q3
$1.17M Buy
22,457
+14,163
+171% +$681K ﹤0.01% 1486
2021
Q2
$379K Buy
8,294
+5,504
+197% +$243K ﹤0.01% 2351
2021
Q1
$123K Buy
+2,790
New +$122K ﹤0.01% 2855
2020
Q1
Sell
-5,225
Closed -$331K 2551
2019
Q4
$331K Buy
5,225
+3,500
+203% +$215K ﹤0.01% 1991
2019
Q3
$103K Buy
1,725
+178
+12% +$12.2K ﹤0.01% 2188
2019
Q2
$108K Buy
+1,547
New +$92.5K ﹤0.01% 2215
2019
Q1
Sell
-726
Closed -$42K 2455
2018
Q4
$42K Buy
+726
New +$49K ﹤0.01% 1851
2017
Q4
Sell
-2,223
Closed -$232K 2357
2017
Q3
$232K Buy
+2,223
New +$227K ﹤0.01% 1314
2017
Q2
Sell
-2,516
Closed -$257K 1823
2017
Q1
$257K Buy
+2,516
New +$258K 0.01% 1165
2015
Q4
Sell
-534
Closed -$55K 1305
2015
Q3
$55K Buy
+534
New +$66.7K 0.01% 385

Other funds holding VEON

Squarepoint's VEON Position: Q2 2026 in Review

Squarepoint reduced its VEON (VEON) stake by 52% in Q2 2026, selling an estimated $314K and leaving 5,583 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #3824.

Squarepoint first reported a position in VEON in Q3 2015 and has held it in 15 quarters since. The position peaked at $1.17M in Q3 2021. 112 funds tracked by Wall St. Rank hold VEON as of Q2 2026.

  • Squarepoint held 5,583 shares of VEON worth $291K as of Q2 2026.
  • Squarepoint sold 6,023 VEON shares in Q2 2026, an estimated $314K.
  • VEON made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3824 holding.
  • Squarepoint first reported a position in VEON in Q3 2015 and has held it in 15 quarters since.
  • Squarepoint's VEON position peaked at $1.17M in Q3 2021.
  • 112 funds tracked by Wall St. Rank held VEON as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.